Cargando…
COVID-19 and Tuberculosis
On March 11, 2020, the WHO declared that coronavirus disease 2019 (COVID-19) can be characterized as a pandemic based on the alarming levels of spread and severity and on the alarming levels of inaction. COVID-19 has received worldwide attention as emergency, endangering international public health...
Autores principales: | Yang, Heng, Lu, Shuihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500119/ https://www.ncbi.nlm.nih.gov/pubmed/32983927 http://dx.doi.org/10.2478/jtim-2020-0010 |
Ejemplares similares
-
The putative mechanism of lymphopenia in COVID-19 patients
por: Wang, Xinling, et al.
Publicado: (2022) -
Real Nano “Light Vaccine” Will Benefit to COVID-19 Pandemic Control
por: Yang, Jianshe
Publicado: (2021) -
Combating COVID-19 with Chloroquine
por: Hong, Wanjin
Publicado: (2020) -
Immunological consequences of strain variation within the Mycobacterium tuberculosis complex
por: Tientcheu, Leopold D., et al.
Publicado: (2017) -
Genetic tracing of HCoV-19 for the re-emerging outbreak of COVID-19 in Beijing, China
por: Yang, Jing, et al.
Publicado: (2020)